The Short Answer
A peptide is a short chain of amino acids. Amino acids are the building blocks your body uses to make proteins; link a few of them together with peptide bonds and you have a peptide. Link enough of them (the usual cutoff is around 50) and you have a protein.
Your body makes thousands of peptides. Many of them work as signals: insulin tells cells to take up glucose, oxytocin triggers labor and bonding, GLP-1 tells your brain you've eaten. Because peptides carry specific messages, drug companies have turned several of them into medicines. Insulin was the first, in the 1920s. The GLP-1 weight-loss drugs are the newest and best known.
"Peptides" has also become shorthand online for a gray market of unapproved research chemicals sold in vials: BPC-157, TB-500, and dozens of others. Those are peptides too, chemically. The difference is that nobody has proven they are safe or effective in people, and they aren't legal drugs. This guide separates the two.
How Peptides Work in the Body
Most peptides act as messengers. A peptide circulates until it reaches a cell with a matching receptor on its surface, binds to it like a key in a lock, and the cell responds. The response depends on the receptor, not on the peptide being "natural":
- Insulin binds insulin receptors and cells pull glucose out of the blood.
- GLP-1 (glucagon-like peptide-1) binds GLP-1 receptors in the pancreas, gut and brain. The result is more insulin after meals, slower stomach emptying, and less appetite. Semaglutide and tirzepatide are engineered versions of this signal that last a week instead of minutes.
- Bremelanotide binds melanocortin receptors in the brain, which is why it affects sexual desire rather than blood flow.
- Oxytocin binds oxytocin receptors in the uterus and brain.
Two practical consequences follow:
- Peptides are usually injected. Stomach acid and digestive enzymes break most peptides down before they're absorbed, which is why insulin and most GLP-1 drugs are injections. Oral versions need special formulation or are small molecules designed to hit the same receptor (orforglipron, the Foundayo pill, is not a peptide at all).
- Peptides are short-lived unless engineered. Natural GLP-1 lasts minutes. Semaglutide was modified to bind to blood proteins so it lasts about a week. That's why dosing frequency differs so much between compounds. See peptide half-life in plain language.
Peptides vs Proteins
| Peptides | Proteins | |
|---|---|---|
| Length | Roughly 2 to 50 amino acids | Usually 50 or more, often hundreds |
| Shape | Mostly short, flexible chains | Fold into complex 3D structures |
| Typical role | Signaling (hormones, neurotransmitter-like messages) | Structure, enzymes, transport, antibodies |
| Examples | Insulin, GLP-1, oxytocin, bremelanotide | Collagen, hemoglobin, antibodies |
The boundary is a convention, not a law of nature. Insulin has 51 amino acids and is often called a peptide hormone anyway. What matters more than length is function: peptides tend to be messages, proteins tend to be machinery.
A related confusion: collagen peptides in supplements are fragments of the collagen protein broken down so they dissolve in water. They are a food product, not a signaling peptide and not related to injectable research peptides.
FDA-Approved Peptide Medicines
Peptide drugs are not fringe. Dozens are approved. A few that readers of this site search for:
| Drug (brand) | What it is | Approved for | FDA approval |
|---|---|---|---|
| Insulin (Humulin R, first recombinant human insulin) | 51-amino-acid hormone | Diabetes | 1982 |
| Semaglutide (Wegovy) | GLP-1 receptor agonist | Chronic weight management; cardiovascular risk reduction | 2021 (injection); oral tablet Dec 2025 |
| Tirzepatide (Mounjaro, Zepbound) | GIP and GLP-1 receptor agonist | Type 2 diabetes (2022); weight management and obstructive sleep apnea (Zepbound, 2023) | 2022 / 2023 |
| Bremelanotide (Vyleesi) | Melanocortin receptor agonist | Hypoactive sexual desire disorder in premenopausal women | 2019 |
| Tesamorelin (Egrifta) | Growth hormone-releasing hormone analog | Excess abdominal fat in HIV lipodystrophy | 2010 |
| Elamipretide (Forzinity) | Mitochondria-targeted peptide (the research name is SS-31) | Barth syndrome | 2025 |
These have something the gray-market vials never have: a label. The label states the indication, the studied dose, the contraindications, and the side-effect rates from controlled trials. Guides: what is tirzepatide, PT-141 (bremelanotide), what tesamorelin does, what SS-31 is, and the peptides for weight loss hub.
"Research Peptides" and How They're Regulated
Most of the peptides discussed on forums are not approved for anything. BPC-157, TB-500, GHK-Cu, KPV, MOTS-c, Semax, Epitalon and similar compounds are sold as "research use only" chemicals. What that means in practice:
- No FDA review. Nobody has checked that the vial contains what the label says, at the purity it claims, or that it's sterile. Our guide to reading a certificate of analysis explains what independent testing can and can't tell you.
- Human evidence is thin. BPC-157, the most popular, has only a handful of tiny human studies. Most "benefits" come from rat and cell research. The peptide clinical evidence guide ranks what has actually been tested in people.
- FDA has flagged many of them. FDA keeps a list of compounding bulk substances that may present significant safety risks, citing immune reactions and missing human safety data. BPC-157, TB-500, KPV, injectable GHK-Cu, Epitalon and Semax are on it.
- The rules are moving. In July 2026 an FDA advisory committee recommended that six peptides (BPC-157, KPV, TB-500, MOTS-c, Semax and Epitalon) be considered for the list that 503A pharmacies may compound from. That's a recommendation, not approval, and FDA still has to act. See after the PCAC votes.
- "Research use only" isn't a loophole. FDA's 2026 warning letters say the label doesn't protect a seller who is clearly marketing to people for human use. See FDA warning letters to research-use-only sellers.
The gap between "approved peptide medicine prescribed by a clinician" and "vial from a website" is the whole story. Same chemistry category, completely different evidence and legal standing.
Why People Take Peptides
The goals people bring to peptides fall into a few buckets. The evidence behind each varies enormously:
- Weight and metabolic health: the strongest evidence in the field. Semaglutide and tirzepatide have large controlled trials and FDA labels. Retatrutide is investigational. See peptides for weight loss.
- Injury recovery and joints: BPC-157, TB-500 and blends like Wolverine and KLOW. Animal data, almost no human trials.
- Growth hormone and body composition: tesamorelin is approved for one narrow use; CJC-1295, ipamorelin and sermorelin are research compounds or discontinued drugs.
- Skin and hair: GHK-Cu has topical research; injected use is less studied.
- Cognition, sleep, longevity: Semax, Selank, DSIP, Epitalon. Mostly small or non-Western studies, cells and animals.
Our best-researched peptides by goal page scores each of these by evidence level and regulatory status.
